ARRB1 Knockout HAP1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the ARRB1 gene in the near-haploid human HAP1 cell line. This polyclonal pool provides a heterogeneous mix of ARRB1-null cells, enabling robust loss-of-function studies without the constraints of single-cell clonal selection. The knockout model is generated via CRISPR/Cas9-mediated gene disruption, creating a versatile tool for investigating ARRB1-dependent cellular processes across a range of experimental contexts.
HAP1 cells are a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia line, originating from a male donor. Their near-haploid karyotype simplifies genetic manipulation and analysis, making them a favored platform for functional genomics and hematopoietic cell biology research. The cells retain key signaling pathways relevant to hematopoiesis and malignancy, offering a physiologically pertinent background for studying signaling networks in a leukemic context.
ARRB1 encodes ??-arrestin-1, a multifunctional adaptor protein that mediates agonist-induced desensitization and clathrin-dependent internalization of G protein-coupled receptors (GPCRs). Upon GPCR phosphorylation by GRKs, ARRB1 translocates to the plasma membrane, binding receptors and facilitating their endocytosis through interactions with clathrin and the AP-2 adaptor complex. Beyond receptor regulation, ARRB1 serves as a scaffold for ??-arrestin-biased signaling, assembling complexes that activate multiple downstream effectors, including the MAPK/ERK cascade, c-Src, JNK3, Akt, and Mdm2. This scaffolding function links GPCR activation to transcription factors such as NF-??B and STAT3, thereby influencing cell proliferation, survival, and inflammatory responses. ARRB1 also interacts with TRAF6 and is implicated in Wnt/??-catenin, Hedgehog, and NF-??B pathway modulation.
In the HAP1 background, disruption of ARRB1 ablates a critical node that couples extracellular stimuli to intracellular signaling cascades. The loss of ARRB1 impedes receptor internalization and desensitization, leading to sustained or altered GPCR signaling that can be probed to dissect ??-arrestin-dependent versus G protein-dependent pathways. Given the near-haploid nature of HAP1 cells, the polyclonal knockout population facilitates straightforward genetic screening and dosage-sensitive studies, while the leukemic origin provides a relevant model for investigating oncogenic signaling and drug response mechanisms in hematological malignancies.
This knockout product is ideally suited for a broad spectrum of investigations, including cancer biology, GPCR pharmacology, drug target identification, and functional genomics. Researchers can employ this model to analyze ARRB1-dependent modulation of MAPK/ERK activity via phospho-ERK western blotting or reporter assays, assess GPCR trafficking by immunofluorescence, and evaluate changes in cell proliferation, apoptosis, or migration using flow cytometry and invasion assays. Co-immunoprecipitation studies can further elucidate altered protein?Cprotein interactions within the ??-arrestin signalosome. For additional information or technical support, please contact Ascent Research.
